Table 1.
Cardiometabolic profile, exemplar loci, and physiological impact of index SNVs at T2D association signals allocated to eight mechanistic clusters.
Mechanistic cluster | Cardiometabolic profile | Number of T2D associations | Exemplar loci | Physiological impact | |
---|---|---|---|---|---|
Insulin secretion | Insulin sensitivity | ||||
Beta-cell +PI | +FG*, +2hG*, +HbAlc, +PI* | 91 | TCF7L2, KCNQ1, CDKAL1, CDKN2A-CDKN2B, SLC30A8 | − | + |
Beta-cell −PI | +FG*, +2hG*, +HbAlc, −PI* | 89 | CDC123-CAMK1D, HNFIB, KCNJ11-ABCC8, HNF4A, HNFIA | − | + |
Residual glycaemic | +FG*, +HbAlc | 389 | GCC1-PAX4-LEP, ANKRD55, GCKR, UBE2E2 | − | − |
Body fat | +body fat, +ASAT* | 273 | ZMIZ1, HMGA2, CTBP1 | + | − |
Metabolic syndrome | +FG*, +FI*, +WHR, +VAT*, −GFAT*, +TG, −HDL, +BP | 166 | IGF2BP2, CCND2, HHEX- IDE, JAZF1, GPSM1 | + | − |
Obesity | +BMI, +WHR, +body fat, +BMR, +TG, −HDL | 233 | FTO, MC4R, MACF1, TMEM18 | + | − |
Lipodystrophy | +FI*, +WHR, −body fat, −GFAT*, +TG, −HDL, +BP | 45 | IRS1, GRB14-COBBL1, PPARG | + | − |
Liver/lipid metabolism | −LDL, −TC, +liver fat, +liver biomarkers | 3 | TOMM40-APOE-GIPR, TM6SF2, PNPLA3 | − | − |
+/−: T2D risk alleles associated with increased/decreased phenotype values.
FG: fasting glucose. FI: fasting insulin. 2hG: two-hour glucose. HbA1c: glycated haemoglobin. PI: proinsulin. BMI: body mass index. WHR: waist-hip ratio. VAT: visceral adipose tissue volume. ASAT: abdominal subcutaneous adipose tissue volume. GFAT: gluteofemoral adipose tissue volume. LDL: low-density lipoprotein cholesterol. HDL: high-density lipoprotein cholesterol. TC: total cholesterol. TG: triglycerides. BMR: basal metabolic rate. BP: blood pressure.
adjusted for BMI.